PANAGORA ASSET MANAGEMENT INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$2,026,000
+97.5%
438,606
+49.6%
0.01%
+80.0%
Q4 2018$1,026,000
-64.4%
293,225
+2.7%
0.01%
-54.5%
Q3 2018$2,879,000
+115.0%
285,646
+54.4%
0.01%
+120.0%
Q2 2018$1,339,000
-32.5%
185,009
-43.7%
0.01%
-37.5%
Q1 2018$1,985,000
-3.0%
328,669
+54.5%
0.01%0.0%
Q4 2017$2,047,000
+112.6%
212,791
+96.3%
0.01%
+100.0%
Q3 2017$963,000
+5564.7%
108,416
+7877.6%
0.00%
Q2 2017$17,000
+21.4%
1,3590.0%0.00%
Q1 2017$14,000
+16.7%
1,3590.0%0.00%
Q4 2016$12,000
-84.2%
1,359
-79.0%
0.00%
Q3 2016$76,000
+322.2%
6,460
+375.3%
0.00%
Q2 2016$18,000
-79.5%
1,359
-75.3%
0.00%
Q1 2016$88,000
+125.6%
5,493
+304.2%
0.00%
Q4 2015$39,0000.0%1,3590.0%0.00%
Q3 2015$39,000
-86.5%
1,359
-83.1%
0.00%
-100.0%
Q2 2015$289,000
-14.2%
8,056
+38.8%
0.00%
-50.0%
Q1 2015$337,000
+178.5%
5,804
+101.5%
0.00%
+100.0%
Q4 2014$121,000
-16.0%
2,881
-22.3%
0.00%0.0%
Q3 2014$144,000
-7.1%
3,709
-25.4%
0.00%0.0%
Q2 2014$155,000
-71.5%
4,972
-62.1%
0.00%
-66.7%
Q1 2014$543,000
+407.5%
13,122
+374.9%
0.00%
Q4 2013$107,000
+12.6%
2,7630.0%0.00%
Q3 2013$95,0002,7630.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders